D. E. Shaw & Co., Inc. - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 120 filers reported holding HOMOLOGY MEDICINES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q2 2022$443,000
-20.0%
225,047
+23.6%
0.00%0.0%
Q1 2022$554,000
+63.9%
182,046
+96.4%
0.00%
Q4 2021$338,000
-83.1%
92,708
-63.5%
0.00%
-100.0%
Q3 2021$2,001,000
+1.2%
254,263
-6.5%
0.00%0.0%
Q2 2021$1,977,000
+280.9%
271,932
+392.7%
0.00%
+100.0%
Q1 2021$519,000
+13.8%
55,197
+36.7%
0.00%
Q4 2020$456,000
-57.5%
40,375
-42.9%
0.00%
-100.0%
Q2 2020$1,073,00070,6640.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q3 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$51,211,00017.25%
Vida Ventures Advisors, LLC 770,845$8,703,0001.79%
AAF Wealth Management, LLC 59,790$675,0000.61%
Vivo Capital, LLC 853,143$9,632,0000.43%
Bellevue Group AG 1,737,122$19,612,0000.22%
PREMIER ASSET MANAGEMENT LLC 77,108$871,0000.18%
Temasek Holdings (Private) Ltd 3,220,293$36,357,0000.16%
American Investment Services, Inc. 36,955$417,0000.13%
Virtus ETF Advisers LLC 24,646$278,0000.12%
FIRST MIDWEST BANK TRUST DIVISION 65,983$745,0000.11%
View complete list of HOMOLOGY MEDICINES INC shareholders